Alan Seth Krasner, Chief Medical Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 7,000 shares at $30.00 ($210K) on 2023-10-17, disclosed to the SEC on 2023-10-19.
Scheduled sale ($210k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BIOD | SELL | 2012-11-05 | $10K | — | Filing → |
| BIOD | SELL | 2011-09-22 | $5K | — | Filing → |